AC Immune SA (NASDAQ: ACIU) announced preliminary Phase 1 data showing its TDP-43 PET tracer ACI-19626 demonstrated increased uptake in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE